Categories
Disposable Biopsy Needle Kit is used in neurosurgery but a specific batch of kits may have microscopic stainless steel debris inside.
Categories
On World AIDS Day, PAHO launches Better with PrEP campaign
On World AIDS Day, PAHO launches Better with PrEP campaign
Cristina Mitchell
28 Nov 2024
Categories
PAHO calls on countries of the Americas to maintain Mpox surveillance and genomic sequencing
PAHO calls on countries of the Americas to maintain Mpox surveillance and genomic sequencing
Cristina Mitchell
26 Nov 2024
Categories
FDA Roundup: November 26, 2024
FDA Roundup: November 26, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-26-2024
Categories
At COP29, PAHO warns that failure to focus on people in vulnerable situations will exacerbate health inequities
At COP29, PAHO warns that failure to focus on people in vulnerable situations will exacerbate health inequities
Oscar Reyes
22 Nov 2024
Categories
FDA Roundup: November 22, 2024
FDA Roundup: November 22, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-22-2024
Categories
Mxbbb Issues Voluntary Nationwide Recall of Umary Acid Hyaluronic Due to the Presence of Diclofenac and Omeprazole
MXBBB is voluntarily recalling 1 lot of UMARY ACID HYALURONIC, 30 CAPLETS 850 MG to the consumer level. The products have been found to have omeprazole and diclofenac. FDA laboratory analysis confirmed that Umary contains diclofenac and omeprazole
Categories
FDA Roundup: November 19, 2024
FDA Roundup: November 19, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-19-2024
Categories
CAF, ECLAC, IDB, and PAHO Advancing Equity and Sustainable Development in the Americas at Brazil’s G20 Summit
CAF, ECLAC, IDB, and PAHO Advancing Equity and Sustainable Development in the Americas at Brazil’s G20 Summit
Cristina Mitchell
19 Nov 2024
Categories
Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling
Endo USA, Inc. is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to potential product carton strength mislabeling.